Results 1 to 10 of about 533,233 (360)
Global epidemiology of cirrhosis — aetiology, trends and predictions
Nature Reviews Gastroenterology and Hepatology, 2023 Hepatitis C virus (HCV) infection remains the leading cause of global deaths related to cirrhosis, followed by alcohol-associated liver disease. The global burden of cirrhosis associated with non-alcoholic fatty liver disease (NAFLD) has increased ...
Daniel Q Huang, , Frank Tacke
exaly +2 more sources
Global epidemiology of alcohol-associated cirrhosis and HCC: trends, projections and risk factors
Nature Reviews Gastroenterology and Hepatology, 2022 Global alcohol consumption per capita rose from 5.5 litres in 2005 to 6.4 litres in 2016 and is projected to increase further to 7.6 litres in 2030. Currently, Europe has the highest levels of alcohol consumption; however, it is projected to be surpassed
Daniel Q Huang +2 more
exaly +2 more sources
A Universal Gut-Microbiome-Derived Signature Predicts Cirrhosis
Cell Metabolism, 2020 SUMMARY Dysregulation of the gut microbiome has been implicated in the progression of nonalcoholic fatty liver disease (NAFLD) to advanced fibrosis and cirrhosis.
Tae Gyu Oh +2 more
exaly +2 more sources
Computed Tomography Images of Spontaneous Portosystemic Shunt in Liver Cirrhosis
Canadian Journal of Gastroenterology and Hepatology, 2022 Spontaneous portosystemic shunt (SPSS) refers to collateral vessels that communicate between the portal vein system and systemic circulation. SPSS mainly includes esophageal varices, gastric varices, left gastric vein, recanalized paraumbilical vein ...
Fangfang Yi +7 more
doaj +1 more source
medRxiv, 2023 Background: Patients with cirrhosis and hepatocellular carcinoma (HCC) require extensive care. Personalized education can improve their outcomes. ChatGPT (Generative Pre-trained Transformer), a natural language processing model, has shown potential to ...
Y. Yeo +10 more
semanticscholar +1 more source
The stratification of cirrhosis [PDF]
Hepatology Research, 2020 Cirrhosis is traditionally seen as an irreversible stage of chronic liver disease although its clinical course may last several years. Overall, the clinical management of patients with cirrhosis is based on the observation of clinical events mostly related to complications of portal hypertension.
Maurice, J, Pinzani, M
openaire +3 more sources
Hypotension in Cirrhosis [PDF]
Clinical Liver Disease, 2019 Circulatory and cardiac compromise in cirrhosis has been well studied. The primary pathophysiology stems from portal hypertension, which is induced from an increased resistance to flow secondary to distorted sinusoidal architecture and is further sustained from an increase in portal venous flow.1 Portal hypertension induces both progressive splanchnic ...
Ravi S, Vora, Ram M, Subramanian
openaire +2 more sources
Clinical and Applied Thrombosis/Hemostasis, 2021 Portal venous system thrombosis (PVST), a common complication of liver cirrhosis, is closely associated with thrombophilia. To explore the association of homocysteine (Hcy), anticardiolipin antibody (aCL), and anti-β2 glycoprotein I antibody (aβ 2 GPI ...
Le Wang +8 more
doaj +1 more source
Diagnosis and Management of Cirrhosis and Its Complications A Review
Journal of the American Medical Association (JAMA), 2023 IMPORTANCE Cirrhosis affects approximately 2.2 million adults in the US. From 2010 to 2021, the annual age-adjusted mortality of cirrhosis increased from 14.9 per 100 000 to 21.9 per 100 000 people. OBSERVATIONS The most common causes of cirrhosis in the
E. Tapper, N. Parikh
semanticscholar +1 more source
BMC Gastroenterology, 2020 Background Endoscopic biliary stenting by endoscopic retrograde cholangiopancreatography (ERCP) is the most common form of palliation for malignant hilar obstruction. However, ERCP in such cases is associated with a risk of cholangitis.
Wen-hui Zhang +7 more
doaj +1 more source